Carbapenemase Gene Transmission in CREC

Carbapenem-resistant Enterobacter cloacae (CREC) is an important clinical reservoir for carbapenemase-encoding genes (CEGs), particularly when resistance determinants are carried on mobile plasmids. The reference study by Chen et al. examines this problem across eight teaching hospitals in Guangdong, China, combining molecular localization, antimicrobial susceptibility testing, conjugation assays, mobile genetic element analysis, and strain genotyping. Its value lies in connecting the presence of carbapenemase genes with their likely mobility and epidemiological distribution rather than treating resistance as a purely phenotypic observation.

Study Background and Research Question

CREC has become a significant component of carbapenem-resistant Enterobacteriaceae surveillance in China. Carbapenemase genes can spread through clonal expansion of a successful strain, horizontal transfer of plasmids, or both processes operating together. The COVID-19-associated period added further concern because changes in antibiotic use, healthcare access, and infection-control practices may alter the selection and dissemination of resistant organisms.

The study asks four related questions: how frequently CEGs occur in CREC isolates from the participating hospitals; whether the genes are located on plasmids, chromosomes, or both; whether they can transfer to a recipient strain; and whether the isolates represent a small number of related clones or a broader, genetically diverse population. The investigators analyzed 54 CREC isolates collected between December 2022 and June 2024, as reported in the reference study.

Key Innovation from the Reference Study

The principal innovation is the integration of several transmission-relevant measurements into one multicenter analysis. A positive PCR result alone establishes that a resistance gene is present, but it does not show whether the determinant is stable, mobile, transferable, or concentrated in a particular clone. Chen et al. address these distinctions by combining plasmid elimination with PCR, broth microdilution, plasmid conjugation, mobile-element characterization, and ERIC-PCR-based genotyping.

This design produces a more useful transmission model. Plasmid localization suggests a mechanism for horizontal spread, conjugation tests whether transfer occurs under laboratory conditions, and ERIC-PCR provides a population-level view of relatedness. The study therefore distinguishes between resistance that may disseminate through mobile DNA and resistance that may expand through clonal persistence. That distinction is especially important for infection-control planning, where a single dominant clone and a broadly shared plasmid require different interventions.

Methods and Experimental Design Insights

The investigators first used a variable-temperature sodium dodecyl sulfate plasmid elimination procedure, followed by PCR, to assess whether CEGs were associated with plasmids or chromosomes. Loss of a gene after plasmid curing supports plasmid localization, whereas persistence after treatment is compatible with chromosomal carriage. Because curing efficiency can vary between strains and plasmids, this approach is best interpreted alongside transfer experiments rather than as an isolated proof of genetic context.

Broth microdilution was used to compare antimicrobial susceptibility between CEG-positive and CEG-negative groups. This phenotypic comparison tests whether the presence of a carbapenemase gene is associated with broader resistance beyond carbapenems. The authors then performed plasmid conjugation experiments and PCR confirmation in transconjugants to assess whether CEGs could move into a recipient strain.

Mobile genetic elements were also examined to identify sequence contexts that could facilitate gene movement. Finally, ERIC-PCR fingerprinting and NTSYS software were used to classify the 54 isolates into relatedness groups. ERIC-PCR is useful for screening strain relationships across a collection, but it does not provide the same resolution as whole-genome sequencing. The methods therefore offer a layered design: gene detection, genetic localization, functional transfer, resistance phenotype, mobile-element context, and population structure.

Protocol Parameters

• Isolate collection: The reference workflow used CREC isolates from eight teaching hospitals and linked laboratory results with patient sex, age group, clinical department, and specimen category; these parameters define the study population rather than a universal sampling requirement.
• Gene localization: Pair variable-temperature SDS plasmid elimination with post-treatment PCR to distinguish plasmid-associated from persistent chromosomal signals, while interpreting curing results in conjunction with conjugation data.
• Resistance phenotyping: Use broth microdilution to compare CEG-positive and CEG-negative isolates under the same laboratory conditions; the paper reports group-level differences rather than a replacement for clinical breakpoint interpretation.
• Transfer assessment: Use plasmid conjugation followed by PCR confirmation of recipient derivatives. A positive laboratory transfer result demonstrates experimental mobility, not necessarily transmission between patients or hospitals.
• Relatedness analysis: ERIC-PCR with computational clustering can screen for related isolates, but highly similar fingerprints should be followed by higher-resolution genomic analysis when outbreak attribution is required.

Core Findings and Why They Matter

CEGs were detected in 46 of 54 isolates, corresponding to 85.19%, according to the published results. The distribution was dominated by bla_NDM-1. Eighteen isolates carried bla_NDM-1 on both chromosome and plasmid, while 25 carried the gene exclusively on plasmids. Two isolates carried only a plasmid-associated bla_IMP, and one carried both plasmid-associated bla_NDM-1 and bla_KPC-2. This pattern emphasizes that plasmids were not a marginal component of the resistance landscape: they were a major genetic platform for clinically relevant carbapenemase determinants.

The CEG-positive group also showed significantly higher resistance rates to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin than the CEG-negative group, with statistical significance reported at P<0.05. The implication is not that every resistance phenotype is caused by the detected carbapenemase gene. Rather, CEG carriage appears to mark isolates with a broader multidrug-resistance background, potentially because resistance genes accumulate on shared plasmids or within successful healthcare-associated lineages.

Conjugation experiments revealed transfer of CEGs from 44 of 46 CEG-positive isolates, a reported success rate of 95.65%. Transfer was observed for 42 of 44 bla_NDM-1-associated cases and both tested bla_IMP cases, whereas the single bla_KPC-2-associated case did not transfer under the assay conditions. These results strongly support the experimental mobility of the dominant determinants, while the non-transfer of bla_KPC-2 illustrates why gene presence and gene mobility should not be treated as synonymous.

Six mobile genetic element types were identified. ISEcp1 was the most prevalent, occurring in 47 of 54 isolates, or 87.04%, and isolates carrying four mobile-element types simultaneously were the most common group at 22 of 54, or 40.74%. Such combinations provide a plausible genetic framework for persistence and reshuffling of resistance determinants, although the study does not by itself establish the exact direction or timing of every transfer event.

ERIC-PCR divided the collection into 17 genotypes. Types E and G were each found in 11 of 54 isolates, or 20.37%, and appeared in different departments across five hospitals. Two type E isolates had a Dice coefficient of 100%. Together, these observations suggest both diversity and localized clonal similarity: CEG dissemination may involve mobile plasmids moving among unrelated backgrounds as well as expansion of closely related strains.

The clinical distribution was also uneven. Men represented 35 of 54 isolates, elderly patients 39 of 54, respiratory medicine 11 of 54, and sputum samples 18 of 54. These findings identify groups and settings for surveillance, but they should not be interpreted as population-level incidence estimates because the study was based on selected clinical isolates rather than a general community sample.

Comparison with Existing Internal Articles

The internal article Carbapenemase Genes in CREC: Dynamics and Plasmid Transmission provides a concise overview of the same study’s emphasis on plasmid-mediated resistance and horizontal transfer. The present analysis extends that framing by explaining how plasmid localization, susceptibility testing, mobile-element profiles, and ERIC-PCR jointly support the transmission interpretation.

Similarly, Plasmid-Borne Carbapenemase Genes in Enterobacter cloacae: Dynamics and Resistance Patterns highlights bla_NDM-1 and multidrug resistance. Its relationship to the reference paper is complementary: the internal article foregrounds resistance patterns, whereas the reference study adds a broader methodological argument about how plasmid transfer and clonal relatedness can be evaluated together.

Limitations and Transferability

The sample size was modest and restricted to eight teaching hospitals in one Chinese province. Consequently, the reported frequencies should not be generalized directly to other regions, hospital types, or bacterial species. The study also uses ERIC-PCR rather than whole-genome sequencing, limiting resolution for distinguishing recent transmission from shared background relatedness.

Plasmid elimination and conjugation provide strong experimental evidence for mobility, but laboratory transfer rates do not equal real-world transmission rates. The assay may favor plasmids compatible with the selected recipient and conditions. In addition, the cross-sectional isolate design cannot reconstruct the chronology of acquisition, identify patient-to-patient transmission chains, or determine whether a mobile element caused each resistance phenotype. These limitations do not undermine the central findings; they define the next level of evidence needed for outbreak reconstruction, such as longitudinal sampling, complete plasmid sequencing, and integrated epidemiological metadata.

Research Support Resources

Why this cross-domain matters, maturity, and limitations

The reference study concerns clinical resistance surveillance, whereas a molecular biology laboratory may use an antimicrobial agent for selection of engineered bacteria. The connection is methodological rather than therapeutic: both settings require careful interpretation of antibiotic exposure, genetic determinants, and selection pressure. For a plasmid selection assay, researchers can use Chloramphenicol (SKU A2512) when the vector and host are validated for chloramphenicol selection. This bacterial protein synthesis inhibitor binds the 50S ribosomal subunit; the product information describes approximate effective concentrations of 25 μg/ml for stringent plasmids and 170 μg/ml for relaxed plasmids, which should be treated as starting guidance rather than universal conditions.

Chloramphenicol is also identified by the systematic name 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide. The product information reports purity above 98.7% and recommends storing solutions at 4°C and solid material at −20°C. These molecular biology uses do not reproduce the clinical CREC experiments and should not be interpreted as treatment for carbapenem-resistant infections. The reagent supports controlled selection or protein synthesis inhibition workflows; it does not establish carbapenemase gene transmission or replace the surveillance methods evaluated by Chen et al.